Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer

Human bladder cancer (BCa) is the most common urogenital system malignancy. Patients with BCa have limited treatment efficacy in clinical practice. Novel biomarkers could provide more crucial information conferring to cancer diagnosis, treatment, and prognosis. Here, we aimed to explore and identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Fei, Tang, Qianqian, Wang, Yejinpeng, Wang, Gang, Qian, Kaiyu, Ju, Lingao, Xiao, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685517/
https://www.ncbi.nlm.nih.gov/pubmed/34938313
http://dx.doi.org/10.3389/fgene.2021.758612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685517/
https://www.ncbi.nlm.nih.gov/pubmed/34938313
http://dx.doi.org/10.3389/fgene.2021.758612

Ejemplares similares